This presentation reviews Axiomer editing oligonucleotides (EONs) structure activity, the potential of Axiomer platform as well as its applicability for the treatment of liver originated disorders.
This is Gerard Platenburg's presentation at the 5th International Conference on Base Editing, Prime Editing & Related Enzymes (Deaminet 2024) in San Diego, California.
… ProQR to Present at Upcoming Scientific Conferences LEIDEN, Netherlands and CAMBRIDGE, … Presentation at the 3 rd Annual Ophthalmic Drugs Conference A presentation will be delivered by Aniz Girach, …
… ProQR to Present at Three Scientific Conferences in April LEIDEN, Netherlands and … (ASGCT). Retinal Cell & Gene Therapy Innovation Summit The conference is being held on Friday, April 26, 2019 in …
… Epidermolysis Bullosa and will Present Data at two Scientific Conferences Key Updates ProQR’s drug candidate … conferences in Salzburg, Austria – EB2017 Research Conference and ESDR Meeting. DEB is a severe genetic skin …
… for QR-010 for Cystic Fibrosis at Two Upcoming Scientific Conferences LEIDEN, Netherlands, Oct. 1, 2015 … program at the 29 th Annual North American Cystic Fibrosis Conference (NACFC) in Phoenix, Arizona, October 8 – 10, 2015 …
… QC, Canada. Gerard Platenburg, co-founder and Chief Scientific Officer at ProQR, will present on Tuesday, October … limited to, statements regarding our presentation at this conference, our Axiomer™ technology, including the continued …
… and presented positive pre-clinical data at two European scientific conferences. WINGS, a Phase 1/2 safety and … F508del mutation were presented at the North American CF conference. A Phase 2 study is currently being designed and …
